SCHEMBL2913340

SCHEMBL2913340

CCCCOC(=O)N1CCCCC1CO

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
GBA2 Q9HCG7 1/20 0.46
LMNA P02545 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
NR1H4 Q96RI1 1/20 0.41
EPHX2 P34913 1/20 0.40
MAPT P10636 1/20 0.40
NPC1 O15118 1/20 0.39
HPGD P15428 1/20 0.39
RAB9A P51151 1/20 0.39
MEN1 O00255 1/20 0.37
GALR3 O60755 1/20 0.37
KMT2A Q03164 1/20 0.37
FKBP1A P62942 1/20 0.37
ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3982504 0.95 POLB (0.53) POLBL3MBTL1GBA2LMNASMN1; SMN2
SCHEMBL6207733 0.95 POLB (0.53) POLBL3MBTL1GBA2LMNASMN1; SMN2
SCHEMBL1982237 0.95 POLB (0.53) POLBL3MBTL1GBA2LMNASMN1; SMN2
SCHEMBL10612338 0.94 GBA2 (0.53) POLBL3MBTL1GBA2LMNASMN1; SMN2
SCHEMBL2170278 0.89 GBA2 (0.49) POLBL3MBTL1GBA2LMNASMN1; SMN2
SCHEMBL7478389 0.89 GBA2 (0.49) POLBL3MBTL1GBA2LMNASMN1; SMN2
SCHEMBL7406503 0.89 GBA2 (0.49) POLBL3MBTL1GBA2LMNASMN1; SMN2
SCHEMBL6119301 0.89 MAPT (0.43) POLBGBA2LMNASMN1; SMN2MAPT
SCHEMBL3036913 0.87 LMNA (0.42) POLBGBA2LMNASMN1; SMN2MAPT
SCHEMBL6645335 0.86 LMNA (0.41) POLBL3MBTL1GBA2LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023064493-A1 COMPOUNDS AND METHODS FOR TREATING CORONAVIRUSES Clear Creek Bio, Inc. (US) 2023-04-20 WO disclosed
EP-3099300-A1 ARYL LACTAM KINASE INHIBITORS Bristol-Myers Squibb Company (US) 2016-12-07 EP disclosed
WO-2015116060-A1 ARYL LACTAM KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2015-08-06 WO disclosed
CN-103102342-B Aminoquinazoline derivative, salts thereof and application method SUNSHINE LAKE PHARMA CO.,LTD. (CN) 2014-10-29 CN disclosed
CN-103102342-A Aminoquinazoline derivative, salts thereof and application method GUANGDONG HEC PHARMACEUTICAL 2013-05-15 CN disclosed
EP-1879884-B1 AZOLE-BASED PHOSPHODIESTERASE INHIBITORS RANBAXY LAB LTD (IN) 2010-08-25 EP disclosed
EP-1879884-A1 AZOLE-BASED PHOSPHODIESTERASE INHIBITORS Ranbaxy Laboratories Limited (IN) 2008-01-23 EP disclosed
WO-2006117653-A1 AZOLE-BASED PHOSPHODIESTERASE INHIBITORS RANBAXY LABORATORIES LIMITED (IN) 2006-11-09 WO disclosed